Katie McCann has had more than one urinary tract infection (UTI), so when she felt…
Subscribe to Updates
Get health & wellness insight updates.
The FDA gave accelerated approval to the biologic Keytruda (pembrolizumab) for patients whose solid cancer tumors have a specific genetic…
Nearly one-third of new drugs approved by the FDA over a recent 10-year period were associated with a postmarket safety…
Scott Gottlieb, President Trump’s nominee to head the FDA, is in most ways a conventional (conservative) choice to head the…
The FDA approved Ocrevus (ocrelizumab) as the first-ever drug to treat primary progressive multiple sclerosis (PPMS), a serious form of…
It is estimated that more than 50 million Americans have arthritis, which is the top cause of disability in the…
The top three categories of pharmaceutical spending in 2016 were biologic anti-inflammatory drugs, diabetes medications and cancer therapies. In its…
MedShadow Foundation is an independent nonprofit health & wellness journalism organization focused on helping to protect lives from the side effects of medication and lower risk with alternative health options.
We help protect your life and the lives of your family by making sure you have the information you need to make informed decisions about the risks, benefits and alternatives to medicines.
Even though MedShadow is nonprofit, we refuse to accept support from pharmaceutical companies or medical device manufacturers. You can be sure that our information is free from the influence of pharmaceutical companies.
Symptoms & Concerns
MedShadow Foundation does not provide medical advice, diagnosis or treatment.
This site complies with the HONcode standard for trustworthy health information.
MedShadow Foundation is a registered 501(c)(3) non-profit organization. MedShadow does not accept advertising or contributions from pharmaceutical companies, medical device manufacturers or political action organizations.
Copyright © 2022, MedShadow Foundation. all rights reserved. Designed by Dante Steward